Eiger BioPharmaceuticals, Inc.
|
-71.03 Million USD
|
99.131%
|
Nanobac Pharmaceuticals, Incorporated
|
-5.92 Million USD
|
89.583%
|
SQZ Biotechnologies Company
|
-64.14 Million USD
|
99.037%
|
Evofem Biosciences, Inc.
|
-17.37 Million USD
|
96.444%
|
Santhera Pharmaceuticals Holding AG
|
94.03 Million USD
|
100.657%
|
Mesoblast Limited
|
-62.38 Million USD
|
99.01%
|
Propanc Biopharma, Inc.
|
-1.53 Million USD
|
59.791%
|
Genus plc
|
73.7 Million USD
|
100.838%
|
VioQuest Pharmaceuticals, Inc.
|
-6.61 Million USD
|
90.658%
|
CNBX Pharmaceuticals Inc.
|
-3.54 Million USD
|
82.587%
|
Marizyme, Inc.
|
-34.28 Million USD
|
98.198%
|
ContraFect Corporation
|
-64.99 Million USD
|
99.05%
|
Nymox Pharmaceutical Corporation
|
-8.77 Million USD
|
92.959%
|
PsyBio Therapeutics Corp.
|
-4.52 Million USD
|
86.354%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-1.4 Million USD
|
55.941%
|
Intellipharmaceutics International Inc.
|
-2.64 Million USD
|
76.644%
|
AXIM Biotechnologies, Inc.
|
-2.32 Million USD
|
73.422%
|
MultiCell Technologies, Inc.
|
-518.04 Thousand USD
|
-19.223%
|
Accustem Sciences Inc.
|
-3.74 Million USD
|
83.514%
|
RVL Pharmaceuticals plc
|
-48.22 Million USD
|
98.719%
|
EV Biologics, Inc.
|
-1.26 Million USD
|
51.258%
|
Emmaus Life Sciences, Inc.
|
3.57 Million USD
|
117.291%
|
Neon Bloom, Inc.
|
-632.4 Thousand USD
|
2.337%
|
Mosaic ImmunoEngineering Inc.
|
-2.28 Million USD
|
72.964%
|
Biomind Labs Inc.
|
-1.03 Million USD
|
40.3%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
Pharming Group N.V.
|
9.87 Million USD
|
106.253%
|
Oncotelic Therapeutics, Inc.
|
-7.16 Million USD
|
91.375%
|
Skye Bioscience, Inc.
|
-13.54 Million USD
|
95.441%
|
Therapeutic Solutions International, Inc.
|
-1.48 Million USD
|
58.476%
|
THC Farmaceuticals, Inc.
|
-25 Thousand USD
|
-2370.512%
|
Arch Therapeutics, Inc.
|
-3.88 Million USD
|
84.099%
|
IMV Inc.
|
-35.52 Million USD
|
98.261%
|
Acro Biomedical Co., Ltd.
|
-15.86 Million USD
|
96.108%
|
Curative Biotechnology, Inc.
|
-2.5 Million USD
|
75.314%
|
GB Sciences, Inc.
|
-1.41 Million USD
|
56.502%
|
Alpha Cognition Inc.
|
-9.7 Million USD
|
93.636%
|
HST Global, Inc.
|
-5303.00 USD
|
-11546.766%
|
CSL Limited
|
4.78 Billion USD
|
100.013%
|
Halberd Corporation
|
-74.27 Thousand USD
|
-731.497%
|
Enzolytics Inc.
|
-2.12 Million USD
|
70.894%
|
Resverlogix Corp.
|
-11.74 Million USD
|
94.74%
|
Affymax, Inc.
|
-14.29 Million USD
|
95.679%
|
SYBLEU INC
|
-141.57 Thousand USD
|
-336.267%
|
Nuo Therapeutics, Inc.
|
-3.06 Million USD
|
79.836%
|
argenx SE
|
-216.02 Million USD
|
99.714%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
Northwest Biotherapeutics, Inc.
|
-55.33 Million USD
|
98.884%
|
Enzon Pharmaceuticals, Inc.
|
1.21 Million USD
|
150.75%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
RespireRx Pharmaceuticals Inc.
|
-1.49 Million USD
|
58.795%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
378.84 Thousand USD
|
263.03%
|
AVAX Technologies, Inc.
|
-6.11 Million USD
|
89.896%
|
Zenith Capital Corp.
|
-8.6 Million USD
|
92.823%
|
Genscript Biotech Corporation
|
-248.71 Million USD
|
99.752%
|
Ember Therapeutics, Inc.
|
-17.42 Thousand USD
|
-3445.307%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-2.44 Million USD
|
74.754%
|
WPD Pharmaceuticals Inc.
|
-176.02 Thousand USD
|
-250.876%
|
American Oriental Bioengineering, Inc.
|
-39.63 Million USD
|
98.442%
|
Provectus Biopharmaceuticals, Inc.
|
-2.89 Million USD
|
78.646%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
Helix BioMedix, Inc.
|
-1.04 Million USD
|
40.971%
|
GlobeStar Therapeutics Corporation
|
6724.00 USD
|
9285.425%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Capstone Therapeutics Corp.
|
-1.74 Million USD
|
64.707%
|
Cotinga Pharmaceuticals Inc.
|
-1.92 Million USD
|
67.847%
|
BioStem Technologies, Inc.
|
-7.55 Million USD
|
91.823%
|
ONE Bio Corp.
|
13.61 Million USD
|
104.537%
|
Reve Technologies, Inc.
|
-181.08 Thousand USD
|
-241.065%
|
Burzynski Research Institute, Inc.
|
- USD
|
Infinity%
|
Wesana Health Holdings Inc.
|
-2.05 Million USD
|
69.974%
|
Agentix Corp.
|
-1.37 Million USD
|
54.975%
|
LadRx Corporation
|
412.28 Thousand USD
|
249.807%
|
Cell Source, Inc.
|
-4.27 Million USD
|
85.544%
|
ProtoKinetix, Incorporated
|
-367.22 Thousand USD
|
-68.19%
|
Regen BioPharma, Inc.
|
1.46 Million USD
|
142.131%
|
Regen BioPharma, Inc.
|
-936.94 Thousand USD
|
34.081%
|
NovAccess Global Inc.
|
-1.03 Million USD
|
40.314%
|
Endonovo Therapeutics, Inc.
|
8.85 Million USD
|
106.976%
|
Itoco Inc.
|
-1.86 Million USD
|
66.954%
|
Rasna Therapeutics, Inc.
|
-379.62 Thousand USD
|
-62.696%
|
Pathfinder Cell Therapy, Inc.
|
-1.11 Million USD
|
44.657%
|
Kadimastem Ltd
|
-2.62 Million USD
|
76.466%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Institute of Biomedical Research Corp.
|
-239.15 Thousand USD
|
-158.26%
|
CytoDyn Inc.
|
-18.02 Million USD
|
96.574%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-79.02 Thousand USD
|
-681.521%
|
Mobile Lads Corp.
|
-2.24 Million USD
|
72.442%
|
NanoSphere Health Sciences Inc.
|
-12.22 Thousand USD
|
-4950.519%
|
Qrons Inc.
|
-40.08 Thousand USD
|
-1440.95%
|
Alseres Pharmaceuticals, Inc.
|
-485.67 Thousand USD
|
-27.168%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
Nascent Biotech, Inc.
|
527.43 Thousand USD
|
217.101%
|
Rebus Holdings, Inc.
|
-951 Thousand USD
|
35.055%
|
ImmunoCellular Therapeutics, Ltd.
|
-1.06 Million USD
|
41.843%
|
International Stem Cell Corporation
|
202 Thousand USD
|
405.756%
|
Bioxytran, Inc.
|
-3.82 Million USD
|
83.832%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
-52.64 Thousand USD
|
-1073.305%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-2.46 Million USD
|
74.913%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-35.86 Million USD
|
98.278%
|
Adhera Therapeutics, Inc.
|
- USD
|
Infinity%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-45 Thousand USD
|
-1272.507%
|
Innovation Pharmaceuticals Inc.
|
-2.73 Million USD
|
77.442%
|
Neutra Corp.
|
-181.24 Thousand USD
|
-240.766%
|
Windtree Therapeutics, Inc.
|
-20.15 Million USD
|
96.936%
|
PureTech Health plc
|
-11.62 Million USD
|
94.688%
|
Coeptis Therapeutics, Inc.
|
-20.15 Million USD
|
96.936%
|
IXICO plc
|
-707 Thousand USD
|
12.641%
|
IntelGenx Technologies Corp.
|
-7.68 Million USD
|
91.963%
|
Gelesis Holdings, Inc.
|
-48.34 Million USD
|
98.722%
|
CSL Limited
|
4.73 Billion USD
|
100.013%
|
Cellectis S.A.
|
-92.63 Million USD
|
99.333%
|